Based on the combined expression of both markers, cancers were categorized into four groups (Table 4): double negative (n = 49, 25%), Ki-67 positive and Her2 negative (n = 91, 47%), Her2 positive and Ki-67 negative (n = 21, 11%), and double positive (n = 34, 17%). This evidence concerns the gene MKI67 and cancer.